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ABSTRACT  14 
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Antimicrobial resistance is dominating scientific media. We are warned of an 16 
impending ‘antibiotic apocalypse’, where mankind faces its biggest threat, untreatable 17 
microbes. However, the world isn’t ending. Scientists are responding to the threat; 18 
new knowledge and chemotherapeutics are being created to safeguard our future. The 19 
future is bright, not gloomy.  20 
 21 
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In the past few years the emergence of antibiotic resistant infections has increased 25 
dramatically. This is largely due to the misuse of antibiotics: misprescribing and 26 
overprescribing by clinicians, patient failure to adhere to the treatment course and the 27 
extensive use of antibiotics in agriculture and aquaculture [1-3].  There is a public 28 
expectation to receive some form of medication when visiting a general practitioner, 29 
and although the medical profession is adapting its practices accordingly, antibiotics 30 
have often been prescribed as a means to satisfy the patient rather than as a course of 31 
treatment [4]. Currently around 700,000 antibiotic resistance-related deaths are 32 
recorded annually, with a projected rise to 10 million by 2050, overtaking cancer as 33 
the leading cause of death worldwide [i]. These projections have led to media hysteria 34 
that has been catalysed by the support of the scientific community. This gloomy 35 
outlook is considered to be a window into a future where all known antibiotics will be 36 
rendered ineffective due to widespread antibiotic resistance. Previously treatable 37 
minor bacterial infections may develop into potentially fatal diseases, invariably 38 
resulting in a dramatic increase in bacteria-borne mortality [ii]. The slim, but real 39 
possibility of a future without antibiotics is recognised by leading academics, 40 
government advisors and doctors worldwide, but does this warrant the casual usage of 41 
the term ‘antibiotic apocalypse’?  42 
 43 
The word apocalypse is defined as "the end of the world or some other event of great 44 
destructive violence" [5]. Can we really consider a return to the days pre-advent of 45 
streptomycin and penicillin as the end of the world? Mankind survived and thrived for 46 
around 200,000 thousand years until the antibacterial properties of penicillin were 47 
discovered in 1928 [6]. The cavalier use of this expression in mainstream media and 48 
scientific articles will undoubtedly impact the general public’s perception of the issue 49 
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of antimicrobial resistance (AMR). Recently, this perception was examined and it was 50 
found that the majority of people do not believe their actions or decisions can 51 
contribute to the development of AMR and that it is not their responsibility to tackle 52 
antibiotic resistance [7]. Indeed, 88% of people believe that antibiotic resistance is 53 
when a human becomes resistant to antibiotics, rendering the antibiotic ineffective 54 
[7]. These misconceptions may in part be down to the dramatisation of the issue as an 55 
unstoppable force, a plight of humanity so great that one person’s input couldn’t 56 
possibly make a difference. In reality, AMR has developed and escalated as a global 57 
healthcare concern as a result of the lack of education and understanding of 58 
individuals about antibiotics. However, the battle is far from lost. In 2015, 1618 peer-59 
reviewed scientific articles were published containing the phrase ‘antimicrobial 60 
resistance’ and the Medical Research Council awarded £10.7 million for UK research 61 
into AMR during the 2015-2016 round [8]. Supporting the hypothesis of an antibiotic 62 
apocalypse among the general public at large serves only to mislead rather than 63 
inform.  64 
 65 
Instead of supporting over-reaction to the subject of AMR, we should encourage 66 
thinking of AMR as an example of a natural coevolutionary system. The Red Queen 67 
hypothesis of coevolution goes some way to explain AMR whereby predators 68 
(bacteria) and prey (humans) sequentially evolve to overcome an evolutionary 69 
advantage of their opponent, driving a continuum of evolutionary push and pull [9]. 70 
Differing speeds of genetic evolution between humans and bacteria result in humans 71 
evolving intellectually rather than physically, with the advent of -lactam antibiotics 72 
[10]. Bacteria then respond accordingly by exploiting -lactamases, regaining the 73 
upper hand. Humans discover new antibiotics, with each discovery, evolving 74 
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intellectually, driven by the eventual resistance of bacteria to each new chemical 75 
class. Bacteria have recently gained the upper hand due to a reduced rate of antibiotic 76 
discovery [10]. However, new advances such as combination antibiotic therapy and 77 
the discovery of new drugs, novel targets and innovative technologies will help 78 
humans regain and retain the evolutionary advantage. Furthermore, our improved 79 
understanding of how resistance occurs, spreads and how to prevent it will ensure our 80 
advantage is not short lived. As Sun Tzu put it in The Art of War, “If you know the 81 
enemy and know yourself, you need not fear the result of a hundred battles. If you 82 
know yourself but not the enemy, for every victory gained you will also suffer a 83 
defeat” [11]. It is rather fortunate we have been studying bacterial resistance almost as 84 
long as we have been discovering antibiotics.  85 
 86 
Evidence for the complexity of this push and pull dynamic between bacteria and 87 
humans can be exemplified by recent epidemiological data. In our possibly 88 
overzealous attempts to tackle AMR by reducing the quantities of antibiotics 89 
prescribed for non-bacterial or immune-susceptible infections such as tonsillitis, we 90 
may have neglected to consider those rare occasions where antibiotics are absolutely 91 
necessary. In the UK, the incidence of Scarlet fever (a complication of untreated or 92 
inappropriately treated tonsillitis due to Streptococcus pyogenes, the group A 93 
streptococcus) has increased since 2013, an inverse correlation to the number of 94 
antibiotic prescriptions per head in the UK (Figure 1). Clearly, improved diagnostics 95 
at the point of care are essential to making the decision for or against antibiotic 96 
administration. Sudden and dramatic changes to our antibiotic prescribing behavior 97 
will invariably result in an epidemiological backlash. A more considered clinical 98 
response to AMR maybe required wherein prevention is pursued instead of panic-99 
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induced kneejerk reactions in response to media hysteria. Our transition into a society 100 
where clinicians are fearful of prescribing antibiotics, and the general public are 101 
equally fearful of taking them needs to be halted. Public perception is key; the 102 
antibiotic apocalypse is not upon us.  103 
 104 
 105 
Figure 1. The number of reported cases of Scarlet Fever (UK) versus the yearly 106 
antibiotic prescriptions per head (UK). Responding to antimicrobial resistance 107 
requires improved, rapid clinical diagnostics at the point of care to ensure antibiotics 108 
are provided when necessary. Data shown in this figure are from [iii-iv].  109 
 110 
Government and private funding is integral to sustaining scientific research and a 111 
wider public understanding of the important issues of the day drives this funding, but 112 
I believe there are considerable ethical boundaries that scientists must operate within. 113 
Feeding and supporting inaccurate sensationalist journalism because it fits our 114 
funding aspirations serves only to mislead the public. As scientists we strive for truth, 115 
we therefore should not discredit scientific fact with sensationalism. When discussing 116 
AMR publically we must provide clear and objective summaries based on hard data, 117 
not assumptions that will fuel public misconception. Referring to the highly unlikely 118 
possibility of a future without antimicrobial treatment as the post-antibiotic era, or 119 
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AMR as a global antibiotic crisis, resonates true without unnecessary scaremongering, 120 
as in this authors view, the truth is scary enough! (Figure 2). 121 
 122 
 123 
Figure 2. The Antibiotic Apocalypse. Is this the end of the world as we know it? 124 
Unlikely. Scientists should promote education over sensationalism using facts, not 125 
fear.  126 
 127 
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